Abstract: A method for delivering at least an active principal A to a human or animal, by administering, in vivo, an active compound of general formula A?V?C?, that is capable of restoring at least the entity A by cleavage, in vivo, of the corresponding attachments between A? and V?, wherein V is a biogenic vectorization compound of general formula X-R-Y, where R represents an aliphatic, cyclic or alicyclic, saturated or unsaturated hydrocarbon chain of 2 to 10 carbon atoms, and X and Y are each a free acid, amine or alcohol function; and A and C are two respectively different active principles, one of which has a chemical function complementary to the function of X, capable of reacting with the latter to give an ionic A? - - - V? or covalent A?—V? attachment that can be cleaved in vivo, and the other of which has a chemical function complementary to the function of Y, capable of reacting with the latter to give an ionic V? - - - C? or covalent V?—C? attachment.

Abstract: A medicinal combination for the treatment of diabetes, in particular of type 2 diabetes, combining a biguanide, in particular an N-dimethylbiguanide, as a first medicament, and an agent for transporting the said biguanide, as a second medicament, said combination comprising: e [sic] a therapeutically active quantity of the biguanide f [sic] and a quantity of transporting agent, previously determined to potentiate the therapeutic activity of the biguanide according to (a).

Abstract: The present invention relates to a compound of formula III, method of making the same and its use in the treatment of diabetes.

Abstract: A medicinal combination for the treatment of diabetes, in particular of type 2 diabetes, combining a biguanide, in particular an N-dimethylbiguanide, as a first medicament, and an agent for transporting the said biguanide, as a second medicament, said combination comprising:

Abstract: The invention concerns the use as medicine of an active compound of general formula A′V′C′, capable of restoring at least the entity &Lgr; by cleaving the corresponding bonds between &Lgr;′ and V′, and optionally capable of restoring likewise the entities V and C by cleaving in vivo the bond V′----- C′ or V′-C′ provided that: V is a vectorizing biogenic compound, of general formula X—R—Y, wherein R represents a hydrocarbon chain of 2 to 10 carbon atoms, aliphatic, cyclic, or alicyclic, saturated or unsaturated, optionally substituted by C1-C5 alkyl groups, and/or hydroxyl groups; X and Y are each a free acid, amine, or alcohol function.

Abstract: Mixed-use building, for business use and for habitation use, including at least one habitation unit located on a level known as a habitation level, at least one business unit located on another level known as a business level, and at least one internal private passage interconnecting the habitation unit and the business unit. The building also includes an entrance known as a habitation entrance, another entrance known as a business entrance, a habitation passage peculiar to the habitation level that communicates with the habitation entrance, and a business passage peculiar to the business level and separate from and independent of the habitation passage. The habitation unit is served solely by the habitation passage, and the business unit is served solely by the business passage.